A. Sewall

905 total citations · 1 hit paper
5 papers, 643 citations indexed

About

A. Sewall is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and General Health Professions. According to data from OpenAlex, A. Sewall has authored 5 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Emergency Medical Services and 1 paper in General Health Professions. Recurrent topics in A. Sewall's work include Cystic Fibrosis Research Advances (4 papers), Tracheal and airway disorders (3 papers) and Pediatric health and respiratory diseases (2 papers). A. Sewall is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Tracheal and airway disorders (3 papers) and Pediatric health and respiratory diseases (2 papers). A. Sewall collaborates with scholars based in United States and United Kingdom. A. Sewall's co-authors include Bruce C. Marshall, Alexander Elbert, Aliza K. Fink, Josh Ostrenga, Kristofer Petren, Christopher H. Goss, Emily A. Knapp, Christopher F. Dowd, Samiya Razvi and Hebe B. Quinton and has published in prestigious journals such as CHEST Journal, Thorax and Annals of the American Thoracic Society.

In The Last Decade

A. Sewall

4 papers receiving 637 citations

Hit Papers

The Cystic Fibrosis Foundation Patient Registry. Design a... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Sewall United States 4 548 103 90 59 51 5 643
T. Pressler Denmark 13 406 0.7× 76 0.7× 179 2.0× 62 1.1× 25 0.5× 28 614
J.L. Whitehouse United Kingdom 13 298 0.5× 50 0.5× 193 2.1× 50 0.8× 62 1.2× 39 498
Mark Dovey United States 11 644 1.2× 145 1.4× 184 2.0× 26 0.4× 72 1.4× 13 874
A Equi United Kingdom 6 421 0.8× 176 1.7× 92 1.0× 29 0.5× 41 0.8× 7 541
Anita Laxova United States 5 660 1.2× 103 1.0× 109 1.2× 25 0.4× 11 0.2× 5 733
Pei Yee Tiew Singapore 16 417 0.8× 157 1.5× 222 2.5× 42 0.7× 141 2.8× 39 717
Sandra A. Lewis United States 11 621 1.1× 419 4.1× 59 0.7× 53 0.9× 137 2.7× 13 892
Arthur Baines United States 10 367 0.7× 54 0.5× 58 0.6× 11 0.2× 35 0.7× 14 434
E. Kerem Israel 8 408 0.7× 123 1.2× 59 0.7× 43 0.7× 28 0.5× 11 491
Lydie Lemonnier France 15 668 1.2× 446 4.3× 57 0.6× 129 2.2× 267 5.2× 34 1.1k

Countries citing papers authored by A. Sewall

Since Specialization
Citations

This map shows the geographic impact of A. Sewall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sewall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sewall more than expected).

Fields of papers citing papers by A. Sewall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sewall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sewall. The network helps show where A. Sewall may publish in the future.

Co-authorship network of co-authors of A. Sewall

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sewall. A scholar is included among the top collaborators of A. Sewall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sewall. A. Sewall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
EVANS, JEFF, David Campbell, Shan Tian, et al.. (2018). IPD2.02 Real-world outcomes in patients with CF treated with ivacaftor: 2016 US and UK CF Registry analyses. Journal of Cystic Fibrosis. 17. S54–S54.
2.
Bessonova, Leona, Nataliya Volkova, Mark Higgins, et al.. (2018). Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor. Thorax. 73(8). 731–740. 143 indexed citations
3.
EVANS, JEFF, David Campbell, Shan Tian, et al.. (2018). IPD2.01 Disease progression in patients with CF treated with ivacaftor: analyses of real-world data from the US and UK CF Registries. Journal of Cystic Fibrosis. 17. S53–S53. 4 indexed citations
4.
Knapp, Emily A., Aliza K. Fink, Christopher H. Goss, et al.. (2016). The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry. Annals of the American Thoracic Society. 13(7). 1173–1179. 324 indexed citations breakdown →
5.
Razvi, Samiya, Lynne M. Quittell, A. Sewall, et al.. (2009). Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005. CHEST Journal. 136(6). 1554–1560. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026